Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1955 2
1956 1
1957 1
1961 3
1962 5
1963 4
1964 5
1965 5
1966 2
1967 6
1968 7
1969 13
1970 5
1971 2
1972 5
1973 3
1974 5
1975 3
1976 9
1977 3
1978 7
1979 10
1980 10
1981 8
1982 14
1983 14
1984 21
1985 16
1986 23
1987 14
1988 24
1989 18
1990 20
1991 22
1992 38
1993 32
1994 21
1995 23
1996 35
1997 31
1998 48
1999 39
2000 46
2001 43
2002 62
2003 66
2004 77
2005 91
2006 85
2007 61
2008 73
2009 98
2010 78
2011 110
2012 127
2013 122
2014 115
2015 109
2016 97
2017 130
2018 123
2019 105
2020 149
2021 13
Text availability
Article attribute
Article type
Publication date

Search Results

2,344 results
Results by year
Filters applied: . Clear all
Page 1
Abdominal aortic aneurysms.
Sakalihasan N, Michel JB, Katsargyris A, Kuivaniemi H, Defraigne JO, Nchimi A, Powell JT, Yoshimura K, Hultgren R. Sakalihasan N, et al. Among authors: yoshimura k. Nat Rev Dis Primers. 2018 Oct 18;4(1):34. doi: 10.1038/s41572-018-0030-7. Nat Rev Dis Primers. 2018. PMID: 30337540 Free article. Review.
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial.
Kudo M, Ueshima K, Ikeda M, Torimura T, Tanabe N, Aikata H, Izumi N, Yamasaki T, Nojiri S, Hino K, Tsumura H, Kuzuya T, Isoda N, Yasui K, Aino H, Ido A, Kawabe N, Nakao K, Wada Y, Yokosuka O, Yoshimura K, Okusaka T, Furuse J, Kokudo N, Okita K, Johnson PJ, Arai Y; TACTICS study group. Kudo M, et al. Among authors: yoshimura k. Gut. 2020 Aug;69(8):1492-1501. doi: 10.1136/gutjnl-2019-318934. Epub 2019 Dec 4. Gut. 2020. PMID: 31801872 Free PMC article.
CD4+ T-cell Immunity in the Peripheral Blood Correlates with Response to Anti-PD-1 Therapy.
Kagamu H, Kitano S, Yamaguchi O, Yoshimura K, Horimoto K, Kitazawa M, Fukui K, Shiono A, Mouri A, Nishihara F, Miura Y, Hashimoto K, Murayama Y, Kaira K, Kobayashi K. Kagamu H, et al. Among authors: yoshimura k. Cancer Immunol Res. 2020 Mar;8(3):334-344. doi: 10.1158/2326-6066.CIR-19-0574. Epub 2019 Dec 23. Cancer Immunol Res. 2020. PMID: 31871122 Free article.
Current status of HIV/AIDS in the ART era.
Yoshimura K. Yoshimura K. J Infect Chemother. 2017 Jan;23(1):12-16. doi: 10.1016/j.jiac.2016.10.002. Epub 2016 Nov 5. J Infect Chemother. 2017. PMID: 27825722 Review.
Comparative morphology of the primate tongue.
Iwasaki SI, Yoshimura K, Shindo J, Kageyama I. Iwasaki SI, et al. Among authors: yoshimura k. Ann Anat. 2019 May;223:19-31. doi: 10.1016/j.aanat.2019.01.008. Epub 2019 Feb 6. Ann Anat. 2019. PMID: 30738175 Review.
Characteristics of SARS-CoV-2 Isolated from Asymptomatic Carriers in Tokyo.
Nagashima M, Kumagai R, Yoshida I, Kawakami M, Nagano M, Asakura H, Kaku E, Kitamura Y, Hasegawa M, Hayashi Y, Chiba T, Sadamasu K, Yoshimura K. Nagashima M, et al. Among authors: yoshimura k. Jpn J Infect Dis. 2020 Jul 22;73(4):320-322. doi: 10.7883/yoken.JJID.2020.137. Epub 2020 Apr 30. Jpn J Infect Dis. 2020. PMID: 32350227 Free article. No abstract available.
Characterization of tumor-infiltrating immune cells in relation to microbiota in colorectal cancers.
Kikuchi T, Mimura K, Ashizawa M, Okayama H, Endo E, Saito K, Sakamoto W, Fujita S, Endo H, Saito M, Momma T, Saze Z, Ohki S, Shimada K, Yoshimura K, Tsunoda T, Kono K. Kikuchi T, et al. Among authors: yoshimura k. Cancer Immunol Immunother. 2020 Jan;69(1):23-32. doi: 10.1007/s00262-019-02433-6. Epub 2019 Nov 26. Cancer Immunol Immunother. 2020. PMID: 31768581
Reply.
Hayashi K, Yoshida M, Manabe SI, Yoshimura K. Hayashi K, et al. Among authors: yoshimura k. J Cataract Refract Surg. 2018 Jun;44(6):790-791. doi: 10.1016/j.jcrs.2018.05.014. Epub 2018 Jul 4. J Cataract Refract Surg. 2018. PMID: 30041753 No abstract available.
Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.
Meyers RL, Maibach R, Hiyama E, Häberle B, Krailo M, Rangaswami A, Aronson DC, Malogolowkin MH, Perilongo G, von Schweinitz D, Ansari M, Lopez-Terrada D, Tanaka Y, Alaggio R, Leuschner I, Hishiki T, Schmid I, Watanabe K, Yoshimura K, Feng Y, Rinaldi E, Saraceno D, Derosa M, Czauderna P. Meyers RL, et al. Among authors: yoshimura k. Lancet Oncol. 2017 Jan;18(1):122-131. doi: 10.1016/S1470-2045(16)30598-8. Epub 2016 Nov 22. Lancet Oncol. 2017. PMID: 27884679 Free PMC article. Clinical Trial.
Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial.
Kudo M, Ueshima K, Yokosuka O, Ogasawara S, Obi S, Izumi N, Aikata H, Nagano H, Hatano E, Sasaki Y, Hino K, Kumada T, Yamamoto K, Imai Y, Iwadou S, Ogawa C, Okusaka T, Kanai F, Akazawa K, Yoshimura KI, Johnson P, Arai Y; SILIUS study group. Kudo M, et al. Among authors: yoshimura ki. Lancet Gastroenterol Hepatol. 2018 Jun;3(6):424-432. doi: 10.1016/S2468-1253(18)30078-5. Epub 2018 Apr 7. Lancet Gastroenterol Hepatol. 2018. PMID: 29631810 Clinical Trial.
2,344 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page